CS Diagnostics Corp. (CSDX)
OTCMKTS · Delayed Price · Currency is USD
0.2380
0.00 (0.00%)
Feb 9, 2026, 4:00 PM EST
CS Diagnostics Market Cap
CS Diagnostics has a market cap or net worth of $59.5 million as of February 10, 2026. Its market cap has decreased by -68.17% in one year.
Market Cap
59.50M
Enterprise Value
59.50M
Revenue
98.73K
Ranking
n/a
PE Ratio
3,067.86
Stock Price
$0.24
Market Cap Chart
Since March 31, 2016, CS Diagnostics's market cap has increased from 738.94K to 59.50M, an increase of 7,951.87%. That is a compound annual growth rate of 56.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 59.50M | -22.20% |
| Dec 31, 2025 | 76.47M | -49.21% |
| Dec 31, 2024 | 150.56M | 38,005.96% |
| Dec 29, 2023 | 395.10K | -47.85% |
| Dec 23, 2022 | 757.61K | 5,499.87% |
| Dec 31, 2021 | 13.53K | -98.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tian'an Technology Group | 145.66M |
| Zomedica | 124.94M |
| RetinalGenix Technologies | 59.54M |
| Positron | 58.27M |
| Vivos | 31.43M |
| Guided Therapeutics | 28.51M |
| PetVivo Holdings | 27.73M |
| Linike Medical Group | 17.16M |